tiprankstipranks
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market

Acumen Pharmaceuticals (ABOS) Technical Analysis

336 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Acumen Pharmaceuticals’s (ABOS) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Acumen Pharmaceuticals is a Sell.
Acumen Pharmaceuticals’s (ABOS) 20-Day exponential moving average is 2.63, while Acumen Pharmaceuticals’s (ABOS) share price is $3.02, making it a Buy.
Acumen Pharmaceuticals’s (ABOS) 50-Day exponential moving average is 2.81, while Acumen Pharmaceuticals’s (ABOS) share price is $3.02, making it a Buy.

Acumen Pharmaceuticals (ABOS) Pivot Points

Jul 18, 2024, 02:28 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.75
2.83
2.99
3.08
3.24
3.32
3.48
Fibonacci
2.83
2.93
2.98
3.08
3.17
3.23
3.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Acumen Pharmaceuticals (ABOS) Moving Averages

Jul 18, 2024, 02:28 PM
Period
Simple
Exponential
MA5
2.91Buy
2.91Buy
MA10
2.61Buy
2.72Buy
MA20
2.45Buy
2.63Buy
MA50
2.87Buy
2.81Buy
MA100
3.36Sell
3.14Sell
MA200
3.26Sell
3.59Sell
Acumen Pharmaceuticals’s (ABOS) 10-Day exponential moving average is 2.72, while Acumen Pharmaceuticals’s (ABOS) share price is $3.02, making it a Buy.
Acumen Pharmaceuticals’s (ABOS) 100-Day exponential moving average is 3.14, while Acumen Pharmaceuticals’s (ABOS) share price is $3.02, making it a Sell.
Acumen Pharmaceuticals’s (ABOS) stock price is $3.02 and Acumen Pharmaceuticals’s (ABOS) 50-day simple moving average is 2.87, creating a Buy signal.
Acumen Pharmaceuticals’s (ABOS) stock price is $3.02 and Acumen Pharmaceuticals’s (ABOS) 100-day simple moving average is 3.36, creating a Sell signal.
Acumen Pharmaceuticals’s (ABOS) stock price is $3.02 and Acumen Pharmaceuticals’s (ABOS) 200-day simple moving average is 3.26, creating a Sell signal.

Acumen Pharmaceuticals (ABOS) Technical Indicators

Jul 18, 2024, 02:28 PM
Name
Value
Implied Action
RSI (14)
64.86
Neutral
STOCH (9,6)
90.54
Sell
STOCHRSI (14)
91.49
Sell
MACD (12,26)
0.04
Sell
ADX (14)
33.67
Neutral
Williams %R
-13.27
Sell
CCI (14)
203.22
Sell
ATR (14)
0.19
-
Ultimate Oscillator
58.30
Neutral
ROC
42.13
Buy
Acumen Pharmaceuticals’s (ABOS) Relative Strength Index (RSI) is 64.86, creating a Neutral signal.
Acumen Pharmaceuticals’s (ABOS) Trend Strength Indicator (ADX) is 33.67, creating a Neutral signal.
Acumen Pharmaceuticals’s (ABOS) Commodity Channel Index (CCI) is 203.22, creating a Sell signal.
Acumen Pharmaceuticals’s (ABOS) Price Rate of Change (ROC) is 42.13, creating a Buy signal.

FAQ

Is ABOS a Buy, Hold, or Sell?
Based on ABOS’s technical indicators, ABOS is a Hold.
    What is ABOS’s RSI (14)?
    ABOS’s RSI (14) is 64.86, which suggests ABOS is a Neutral.
      What is ABOS’s MACD?
      ABOS’s MACD is 0.04, which suggests ABOS is a Sell.
        What is ABOS’s 5-day moving average?
        ABOS’s 5-day moving average is 2.91, which suggests ABOS is a Buy.
          What is ABOS’s 20-day moving average?
          ABOS 20-day moving average is 2.45, which suggests ABOS is a Buy.
            What is ABOS’s 50-day moving average?
            ABOS’s 50-day moving average is 2.87, which suggests ABOS is a Buy.
              What is ABOS’s 200-day moving average?
              ABOS’s 200-day moving average is 3.26, which suggests ABOS is a Sell.
                What is ABOS’s Williams % R (14)?
                ABOS’s Williams % R (14) is -13.27, which suggests ABOS is a Sell.
                  What is ABOS’s CCI (14)?
                  ABOS’s CCI (14) is 203.22, which suggests ABOS is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis